Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | President AS and AET | June 14, 2024 | June 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 14, 2024 · Filed June 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63 |
Ending reported balance
After 2024-06-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-14 · Exercise / conversion · Acquired 4,000 · Balance 4,063 Row 2 · 2024-06-14 · Sale · Disposed 4,000 · Balance 63 |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.93 · Expires 2027-03-01 | Direct | 0 |
Reported balance
After 2024-06-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-14 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 446 | $39.87 | $17,782.02 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 554 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,146 Underlying: Common Stock · 554 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 554 | $94.31 | $52,250.12 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.26 to $94.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 554 | $39.87 | $22,087.98 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 10, 2020 01:55 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 500 | $81.82 | $40,910.00 |
DisclosureSEC source: 0001127602-20-028543 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 224 | $54.41 | $12,187.84 |
DisclosureSEC source: 0001127602-20-012799 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:47 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 31,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · derivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 124 | $94.64 | $11,735.36 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:47 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009059 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:28 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 187 | $104.18 | $19,481.29 |
DisclosureSEC source: 0001127602-20-003997 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 44 | $106.24 | $4,674.56 |
DisclosureSEC source: 0001127602-20-000494 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225 Read SEC document |
| December 31, 2019 Filed Feb 13, 2020 21:56 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 933.285 | $111.83 | $104,369.26 |
DisclosureSEC source: 0001127602-20-005324 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 933.285 F1 · date: As of December 31, 2019. F2 · balance_after: Shares of stock in the 401 (K) Conmed fund. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 18:56 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 51 | $91.34 | $4,658.34 |
DisclosureSEC source: 0001127602-19-029662 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181 Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 21:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 500 | $101.76 | $50,880.00 |
DisclosureSEC source: 0001127602-19-027522 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:54 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 12 | $81.29 | $975.48 |
DisclosureSEC source: 0001127602-19-023621 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630 Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:11 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,511 | $82.00 | $123,897.47 |
DisclosureSEC source: 0001127602-19-016498 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618 Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 18:26 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 45 | $79.02 | $3,555.90 |
DisclosureSEC source: 0001127602-19-014024 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,129 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 126 | $78.76 | $9,923.76 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,084 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 138 | $78.76 | $10,868.88 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,785 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:53 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009957 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 19:27 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 15 | $60.99 | $914.85 |
DisclosureSEC source: 0001127602-19-000557 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523 Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:52 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 12 | $75.26 | $903.12 |
DisclosureSEC source: 0001127602-18-029112 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,508 Read SEC document |
| September 14, 2018 Filed Sep 17, 2018 20:54 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,500 | $80.43 | $120,651.00 |
DisclosureSEC source: 0001127602-18-027795 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,496 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.39 to $80.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 17:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 13 | $69.54 | $904.02 |
DisclosureSEC source: 0001127602-18-022106 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,996 Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 18:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 33 | $60.16 | $1,985.28 |
DisclosureSEC source: 0001127602-18-013621 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,983 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2028-03-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 119 | $59.96 | $7,135.24 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 127 | $59.96 | $7,614.92 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,669 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-009997 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 17:36 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 17 | $48.39 | $822.63 |
DisclosureSEC source: 0001127602-17-022513 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,371 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 19:26 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 543 | $42.19 | $22,909.17 |
DisclosureSEC source: 0001127602-17-013834 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,354 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 33,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2027-03-01 F3 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275 Underlying: Common Stock · 425 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 139 | $41.93 | $5,828.27 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 131 | $41.93 | $5,492.83 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009993 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.